Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer
Pfizer
Mario Campone; Michelino De Laurentiis; Komal Jhaveri; Xichun Hu; Sylvain Ladoire; Anne Patsouris; Claudio Zamagni; Jiuwei Cui; Marina Cazzaniga; Timucin Cil; Katarzyna J Jerzak; Christian Fuentes; Tetsuhiro Yoshinami; Alvaro Rodriguez-Lescure; Ahmet Sezer; Andrea Fontana; Valentina Guarneri; Andrea Molckovsky; Marie-Ange Mouret-Reynier; Umut Demirci; Yongqiang Zhang; Olga Valota; Dongrui R Lu; Marcella Martignoni; Janaki Parameswaran; Xin Zhi; Erika P Hamilton; VERITAC-2 Study Group